|
Volumn 102, Issue 23, 2000, Pages 2867-2872
|
1α,25-Dihydroxyvitamin D3 and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL
a a a a a a |
Author keywords
Anticoagulants; Coagulation; Thrombosis
|
Indexed keywords
22 OXACALCITRIOL;
CALCITRIOL;
CALCITRIOL DERIVATIVE;
THROMBOMODULIN;
TUMOR NECROSIS FACTOR;
DRUG DERIVATIVE;
LOW DENSITY LIPOPROTEIN;
OXIDIZED LOW DENSITY LIPOPROTEIN;
THROMBOPLASTIN;
TUMOR NECROSIS FACTOR ALPHA;
ANTICOAGULANT THERAPY;
ARTICLE;
DRUG EFFECT;
DRUG POTENCY;
HUMAN;
HUMAN CELL;
LIPID PEROXIDATION;
MONOCYTE;
PRIORITY JOURNAL;
RECEPTOR AFFINITY;
THROMBOSIS;
TRANSCRIPTION REGULATION;
CELL CULTURE;
CELL LINE;
CELL STRAIN U937;
DOWN REGULATION;
METABOLISM;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
UPREGULATION;
CALCITRIOL;
CELL LINE;
CELLS, CULTURED;
DOWN-REGULATION;
HUMANS;
LIPOPROTEINS, LDL;
MONOCYTES;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
THROMBOMODULIN;
THROMBOPLASTIN;
TUMOR NECROSIS FACTOR-ALPHA;
U937 CELLS;
UP-REGULATION;
|
EID: 0034610182
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/01.CIR.102.23.2867 Document Type: Article |
Times cited : (131)
|
References (21)
|